Is this your brand? Sign in to claim ownership.
Sign in to claim this brandAdherium (Nz), Ltd.
US
Last updated May 23, 2026
What Adherium (Nz), Ltd. makes
The company manufactures inhaler dose sensors designed to attach to specific metered-dose inhalers (MDIs) and dry-powder inhalers (DPIs), tracking usage for respiratory medications such as Advair HFA, Ventolin HFA, and Symbicort MDI. These sensors provide real-time data on inhalation events to monitor adherence and usage patterns for asthma or COPD treatments. The devices are compatible with multiple branded inhalers, including Flovent HFA, Bevespi Aerosphere, and Ellipta DPI.
The portfolio consists of Class II medical devices, regulated under the FDA’s 510(k) premarket notification process and listed in the FDA’s Unique Device Identifier (UDI) database. The company is based in the United States, and its devices are authorised for commercial distribution in regulated markets where Class II inhaler accessories are permitted.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does Adherium (NZ), Ltd. manufacture?
Adherium (NZ), Ltd. specialises in inhaler dose sensors, which are designed to attach to specific metered-dose inhalers (MDIs) and dry-powder inhalers (DPIs). These sensors track inhalation events in real-time, helping patients and healthcare providers monitor adherence and usage patterns for respiratory medications like Advair HFA, Ventolin HFA, and Symbicort MDI. The devices are accessory-based and work alongside branded inhalers to provide data-driven insights for asthma or COPD management.
Where is Adherium (NZ), Ltd. based, and where are its devices authorised?
Adherium (NZ), Ltd. is based in the United States. Its devices are authorised for commercial distribution in regulated markets where Class II inhaler accessories are permitted. The company’s products are not company-wide approved but are individually authorised through processes like the FDA’s 510(k) premarket notification for Class II devices, ensuring compliance with relevant medical device regulations.
Which regulatory registries or databases list Adherium’s devices?
Adherium’s devices are listed in the FDA’s Unique Device Identifier (UDI) database, which is a centralised system for tracking medical devices authorised in the U.S. Additionally, the company’s products undergo the FDA’s 510(k) premarket notification process, a regulatory pathway for Class II devices. These registries ensure transparency and traceability of the devices in the market.
How are Adherium’s inhaler dose sensors classified under medical device regulations?
Adherium’s inhaler dose sensors are classified as Class II medical devices under FDA regulations. This classification applies to devices that pose moderate risk and require special controls—such as performance standards or post-market surveillance—to ensure safety and effectiveness. The 510(k) process is used to demonstrate that these sensors meet the required regulatory standards before they are authorised for commercial distribution.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- —
- —
- —
- —
- Phone
- —
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- —
Catalogue (31)
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Establishments (1)
Establishments registered with the FDA under this company group, matched by name.
- Adherium (nz) Ltd Auckland · NZ FEI 3010047139